13F Data
13F filer · CIK 1773195

Affinity Asset Advisors, LLC

NEW YORK, NY · filing since Q4 2020 · last filing Aug 13, 2026
Reported value
$2.2B
+$276.2M vs prior
Positions
113
New / sold out
26 / 18
Added / reduced
33 / 30
Turnover
24.4%
buys $505.3M · sells $596.1M
Top-10 weight
39.4%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewFIRST TRACKS BIOTHERAPEUTICS+2,032,012–+$40.9M
NewMODERNA INCPUT+500,000–+$35.0M
AddedROIVANT SCIENCES LTD+950,000+33.9%+$33.6M
NewARK ETF TRCALL+750,000–+$31.5M
AddedAVALO THERAPEUTICS INC+1,559,160+116.3%+$28.8M
AddedREVOLUTION MEDICINES INC+150,000+150.0%+$28.1M
NewLLYELI LILLY & COCALL+20,000–+$24.0M
AddedINSMED INC+170,000+35.4%+$18.1M
AddedBELITE BIO INC+100,000+153.8%+$15.4M
NewIDEAYA BIOSCIENCES INC+400,000–+$14.9M
49 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outSPYSTATE STR SPDR S&P 500 ETF TPUT-200,000-100.0%$-130.1M
Sold outCENTESSA PHARMACEUTICALS PLC-1,400,000-100.0%$-55.6M
Sold outARCELLX INC-362,764-100.0%$-41.7M
ReducedAPOGEE THERAPEUTICS INC-297,926-23.2%$-39.5M
ReducedTEVA PHARMACEUTICAL INDS LTD-1,026,000-73.3%$-34.8M
Sold outTERNS PHARMACEUTICALS INC-562,631-100.0%$-29.7M
ReducedMODERNA INCCALL-325,000-40.6%$-22.8M
Sold outASCENDIS PHARMA A/S-95,000-100.0%$-21.7M
Sold outBRISTOL-MYERS SQUIBB COCALL-300,000-100.0%$-18.2M
ReducedCYTOKINETICS INC-150,483-21.5%$-12.8M
38 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2020: $188.7MQ1 2021: $294.5MQ2 2021: $279.3MQ3 2021: $396.0MQ4 2021: $275.4MQ1 2022: $625.0MQ2 2022: $237.2MQ3 2022: $358.3MQ4 2022: $255.0MQ1 2023: $303.0MQ2 2023: $286.3MQ3 2023: $355.5MQ4 2023: $547.5MQ1 2024: $807.8MQ2 2024: $867.5MQ3 2024: $732.8MQ4 2024: $746.0MQ1 2025: $1.0BQ2 2025: $732.2MQ3 2025: $1.1BQ4 2025: $1.8BQ1 2026: $1.9BQ2 2026: $2.2B
Q4 2020Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1ROIVANT SCIENCES LTDSHS3,750,000$132.7M6.00%
2APOGEE THERAPEUTICS INCCOM987,000$131.0M5.92%
3SPYRE THERAPEUTICS INCCOM NEW1,279,134$113.6M5.13%
4XENON PHARMACEUTICALS INCCOM1,595,000$96.3M4.35%
5ERASCA INCCOM5,250,000$96.2M4.35%
6INSMED INCCOM PAR $.01650,000$69.3M3.13%
7PRAXIS PRECISION MEDICINES ICOM NEW185,000$61.9M2.80%
8ALKERMES PLCSHS1,125,000$58.9M2.66%
9ORUKA THERAPEUTICS INCCOM590,000$56.2M2.54%
10ANAPTYSBIO INCCOM826,109$55.8M2.52%
103 more rows. Subscribe for $29/month to see every row, download the data and use the API.